Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Similarly, there were no differences between groups in biochemical measurements, such as TC, TG, serum K + , serum Ca + , creatinine and total vitamin D (Table 1).Characteristics of study participants by quartiles of OsteocalcinVariablesG1G2G3G4PNumber94949494Male/FemaleM 60 F 34M 62 F 32M 59 F 35M 54 F 40Osteocalcin (ng/ml)8.73 (7.50 9.82)12.38 (11.43 13.19)*15.10 (14.51 16.00)*#21.20 (18.70 26.27)*#✱ < 0.001TBR (%)0.00 (0.00 0.00)0.00 (0.00 0.00)0.00 (0.00 0.04)0.00 (0.00 0.47)0.71TIR (%)53.94 (34.01 70.93)58.43 (40.47 76.11)68.64 (34.76 86.93)*72.20 (45.55 85.93)*#0.001TAR (%)45.24 (29.07 64.29)41.57 (23.15 59.44)30.86 (13.03 62.84)*26.74 (13.32 53.07)*#0.001Age (years)55.68 ± 11.4356.49 ± 11.1353.27 ± 3.8055.30 ± 12.840.403Weight (Kg)70.41 ± 12.3070.25 ± 12.2071.7 ± 12.6368.15 ± 12.690.288High (m)1.66 ± 0.081.66 ± 0.081.68 ± 0.091.67 ± 0.090.467BMI (kg/m2)25.37 ± 3.6225.03 ± 3.2125.08 ± 3.2724.74 ± 3.700.669Creatinine (umol/L)57.16 ± 16.3458.02 ± 13.3556.27 ± 14.8759.24 ± 17.450.615Duration (years)7.00 (2.00 15.00)8.00 (2.75 15.00)6.00 (2.00 12.00)6.00 (1.00 11.00)0.419SBP (mmHg)130.00 (127.75 145.00)130 (124.75 140.00)130 (129.50 140.00)130.00 (120.00 138.50)0.499DBP (mmHg)78.00 (75.00 86.25)79.00 (75.00 85.25)79.00 (75.00 87.50)78.00 (74.00 82.25)0.705K (mmol/L)3.82 ± 0.373.8 ± 0.333.86 ± 0.323.84 ± 0.290.581Ca (mmol/L)2.21 ± 0.122.24 ± 0.122.21 ± 0.102.19 ± 0.110.053TC (mmol/L)4.42 ± 1.144.63 ± 1.074.56 ± 0.954.71 ± 1.040.297TG (mmol/L)1.53 (1.10 2.32)1.61 (1.12 2.28)1.50 (1.10 2.35)1.44 (1.01 1.98)0.602HbA1C (%)9.25 ± 1.739.00 ± 1.988.62 ± 2.21*8.49 ± 1.94*0.045Vit D (ng/ml)24.11 ± 6.8425.56 ± 6.6425.15 ± 6.8623.73 ± 6.270.218MBG (mmol⁄ L)10.35 ± 2.029.89 ± 2.129.53 ± 2.49*9.21 ± 1.79*#0.002SD2.86 ± 1.012.59 ± 0.992.35 ± 0.88*2.44 ± 0.97*0.008CV0.28 ± 0.080.28 ± 0.100.24 ± 0.06*#0.26 ± 0.08✱ < 0.001LBGI0.37 (0.00 1.74)0.50 (0.05 1.50)0.37 (0.01 1.03)0.74 (0.21 1.81)*✱0.043HBGI10.26 (7.08 14.40)9.61 (6.07 13.82)7.13 (3.61 13.82)*6.74 (3.75 12.87)*#0.002MAGE (mmol⁄ L)5.30 ± 2.034.78 ± 1.764.75 ± 1.724.89 ± 1.690.171ADDR (mmol⁄ L)27.27 (20.61 37.24)25.31 (18.53 32.40)20.84 (13.91 32.64)*21.29 (13.15 31.86)*0.001MODD (mmol⁄ L)2.44 (1.68 3.37)2.38 (1.76 3.52)2.07 (1.35 2.56)*#2.05 (1.43 3.16)0.003Data are presented as means ± SD, median (25% and 75%interquartiles), and count (percentages) according to characteristics of the distribution.

Source: Comparison of clinical characteristics between groups. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

A total of 376 participants were recruited from the Department of Endocrinology in Jinling Hospital of Southern Medical University according to the diagnostic criteria published by the WHO in 1999 [].

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Circulating osteocalcin is associated with time in range and other metrics assessed by continuous glucose monitoring in type 2 diabetes

Study design awaiting verification · Diabetology & Metabolic Syndrome · 2022

Original publication title

Circulating osteocalcin is associated with time in range and other metrics assessed by continuous glucose monitoring in type 2 diabetes

Jun Liu; Yinghua Wei; Pu Zang; Wei Wang; Zhouqin Feng; Yanyu Yuan; Hui Zhou; Zhen Zhang; Haiyan Lei; Xinyi Yang; Jun Liu; Bin Lu; Jiaqing Shao

© The Author(s) 2022

Original publication · Publisher record · CC BY 4.0 · CC0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Circulating osteocalcin is positively correlated with TIR and negatively correlated with MODD, ADDR, and MAGE. Osteocalcin may have a beneficial impact on glucose homeostasis in T2DM patients.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Osteocalcin, a protein secreted mainly by mature osteoblasts, has been shown to be involved in glucose metabolism through various pathways. However, few studies has explored the association between osteocalcin and Time in range (TIR). Continuous glucose monitoring (CGM): derived metrics, such as TIR and other indexes have been gradually and widely used in clinical practice to assess glucose fluctuations. The main purpose of this study was to investigate the correlation between osteocalcin and indexes from CGM in patients with type 2 diabetes mellitus (T2DM).

Source: Background

Abstract: What methods does the paper describe?

The total number of 376 patients with T2D were enrolled, all of them performed three consecutive days of monitoring. They were divided into four groups on account of the quartile of osteocalcin. Time in range, Time below range (TBR), Time above range(TAR) and measures of glycemic variability (GV) were assessed for analysing. After a 100 g standard steamed bread meal, blood glucose (Glu0h Glu0.5 h, Glu1h, Glu2h, GLu3h), C-peptide (Cp0h, Cp0.5 h, Cp1h, Cp2h, Cp3h), serum insulin (INS0h, INS0.5 h, INS1h, INS2h, INS3h) concentrations at different time points were obtained.

HOMA-IS, HOMA-βwas calculated to evaluate insulin sensitivity and insulin secreting of the participants.

Source: Method

Abstract: Results

Patients with higher osteocalcin level had higher TIR (P < 0.05). Spearman correlation analysis showed that osteocalcin was positively correlated with TBR (although the P value for TBR was greater than 0.05) (r = 0.227, P < 0.001 r = 0.068, P = 0.189) and negatively correlated with TAR (− 0.229, P < 0.001). Similarly, there was a negative correlation between osteocalcin and glycemic variability (GV) indicators, including SD, MBG, MODD, ADDR, and MAGE (P value of MAGE > 0.05).

Multiple stepwise regression showed that osteocalcin was an independent contributor to TIR, TAR and HOMA-IS.

Source: Results

Abstract: Conclusion

Circulating osteocalcin is positively correlated with TIR and negatively correlated with MODD, ADDR, and MAGE. Osteocalcin may have a beneficial impact on glucose homeostasis in T2DM patients.

Source: Conclusion
Authors’ abstract

Background

Osteocalcin, a protein secreted mainly by mature osteoblasts, has been shown to be involved in glucose metabolism through various pathways. However, few studies has explored the association between osteocalcin and Time in range (TIR). Continuous glucose monitoring (CGM): derived metrics, such as TIR and other indexes have been gradually and widely used in clinical practice to assess glucose fluctuations. The main purpose of this study was to investigate the correlation between osteocalcin and indexes from CGM in patients with type 2 diabetes mellitus (T2DM).

Method

The total number of 376 patients with T2D were enrolled, all of them performed three consecutive days of monitoring. They were divided into four groups on account of the quartile of osteocalcin. Time in range, Time below range (TBR), Time above range(TAR) and measures of glycemic variability (GV) were assessed for analysing. After a 100 g standard steamed bread meal, blood glucose (Glu0h Glu0.5 h, Glu1h, Glu2h, GLu3h), C-peptide (Cp0h, Cp0.5 h, Cp1h, Cp2h, Cp3h), serum insulin (INS0h, INS0.5 h, INS1h, INS2h, INS3h) concentrations at different time points were obtained.

HOMA-IS, HOMA-βwas calculated to evaluate insulin sensitivity and insulin secreting of the participants.

Results

Patients with higher osteocalcin level had higher TIR (P < 0.05). Spearman correlation analysis showed that osteocalcin was positively correlated with TBR (although the P value for TBR was greater than 0.05) (r = 0.227, P < 0.001 r = 0.068, P = 0.189) and negatively correlated with TAR (− 0.229, P < 0.001). Similarly, there was a negative correlation between osteocalcin and glycemic variability (GV) indicators, including SD, MBG, MODD, ADDR, and MAGE (P value of MAGE > 0.05).

Multiple stepwise regression showed that osteocalcin was an independent contributor to TIR, TAR and HOMA-IS.

Conclusion

Circulating osteocalcin is positively correlated with TIR and negatively correlated with MODD, ADDR, and MAGE. Osteocalcin may have a beneficial impact on glucose homeostasis in T2DM patients.

Publication and source details

Original title: Circulating osteocalcin is associated with time in range and other metrics assessed by continuous glucose monitoring in type 2 diabetes

Jun Liu; Yinghua Wei; Pu Zang; Wei Wang; Zhouqin Feng; Yanyu Yuan; Hui Zhou; Zhen Zhang; Haiyan Lei; Xinyi Yang; Jun Liu; Bin Lu; Jiaqing Shao

Diabetology & Metabolic Syndrome · 2022

© The Author(s) 2022https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.http://dx.doi.org/10.13039/501100001809National Natural Science Foundation of China81873174818731748187317481873174818731748187317481873174818731748187317481873174818731748187317481873174Liu Jun Wei Yinghua Zang Pu Wang Wei Feng Zhouqin Yuan Yanyu Zhou Hui Zhang Zhen Lei Haiyan Yang Xinyi Liu Jun Lu Bin Shao Jiaqing Key Research and Development Plan Project of Jiangsu Province: Social Development Projects.BE2020701BE2020701BE2020701BE2020701BE2020701BE2020701BE2020701BE2020701BE2020701BE2020701BE2020701BE2020701BE2020701Liu Jun Wei Yinghua Zang Pu Wang Wei Feng Zhouqin Yuan Yanyu Zhou Hui Zhang Zhen Lei Haiyan Yang Xinyi Liu Jun Lu Bin Shao Jiaqing

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T08:07:10.185858+00:00

DOI: 10.1186/s13098-022-00863-4 · PMC9351112